site stats

Jonathan hepple rosetta capital

Nettet31. des. 2013 · Jonathan Hepple Ph.D: Co-Founder and Partner: 00: 0: 0: Buckinghamshire, United Kingdom To view Rosetta Capital V’s complete team members history, request access » Rosetta Capital V Returns Data. The below charts are illustrative of the type of graphical data available to our clients and do not represent live data. Nettet30. mar. 2024 · Dr Jonathan Hepple, Managing Partner, Rosetta, said, "We believe this is an attractive portfolio of biotech assets, representing a mix of companies in late-stage …

ROSETTA CAPITAL VI GP LIMITED people - Find and update …

NettetMission Therapeutics Welcomes Co-founder of Rosetta Capital, Jonathan Hepple, to its Board of Directors CAMBRIDGE, England--(BUSINESS WIRE)--Mission Therapeutics (“Mission”), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), today announces the appointment of Jonathan … NettetJonathan Hepple represents Rosetta Capital Ltd. where he is one of the founding Partners. Jonathan has over 17 years of investment experience in the life sciences, … 18 等于多少米 https://nautecsails.com

Mission Therapeutics Welcomes Co-founder of Rosetta Capital, Jonathan …

NettetJonathan Hepple Load 2 more About The Fund Rosetta Capital is a venture capital firm headquartered in Buckinghamshire, United Kingdom. The firm invests in companies operating in the life science and medical technology sectors. The firm has raised five funds to date and specilaizes in acquiring secondary direct portfolios. Nettet15. nov. 2024 · In February 2013, Rosetta Capital completed a secondary transaction to acquire a portfolio of thirteen life sciences assets from Karolinska Development, ... Rosetta partners Jonathan Hepple and Ken MacLeod have joined the boards of acquired portfolio companies and are actively involved in strategic decision making. Nettet18. feb. 2014 · Rosetta Capital has led a CHF 60 million ($66 million) Series B financing round in biopharmaceutical company Novimmune. The funding round included a new private investor as well as existing investors. 18 等于多少厘米

Jon Hepple, Rosetta Capital Ltd: Profile and Biography

Category:Mission Therapeutics : Welcomes Co-founder of Rosetta Capital, Jonathan …

Tags:Jonathan hepple rosetta capital

Jonathan hepple rosetta capital

Jonathan Hepple – Rosetta Capital Limited

NettetJonathan Hepple is a co-founder and Director of Rosetta Capital. He has more than 20 years’ investment experience in the life sciences industry. His previous roles include …

Jonathan hepple rosetta capital

Did you know?

NettetView Jonathan Hepple’s professional profile on LinkedIn. LinkedIn is the world’s largest business network, helping professionals like Jonathan Hepple discover inside … NettetCBIO / Catalyst Biosciences Inc - CBIO / Catalyst Biosciences Inc. / Rosetta Capital V LP - SC 13D Activist Investment - SC 13D - August 28, 2015

NettetJonathan Hepple is a co-founder and Director of Rosetta Capital. He has more than 20 years’ investment experience in the life sciences industry. His previous roles include Founder and Director of BioScience Managers and Investment Analyst at … NettetJonathan Paul HEPPLE. Filter appointments ... ROSETTA CAPITAL LIMITED (03941653) Company status Active Correspondence address Tullig House, 5 The Close, Ashendon, Aylesbury, Buckinghamshire, England, HP18 0HX. Role Active Director Appointed on 28 ...

NettetROSETTA CAPITAL VI GP LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, ... HEPPLE, Jonathan Paul, Dr Correspondence address C/O Rosetta Capital Limited, Rectory House Thame Road, Haddenham, Bucks, England, HP17 8DA NettetJonathan Paul HEPPLE. Filter appointments ... ROSETTA CAPITAL LIMITED (03941653) Company status Active Correspondence address Tullig House, 5 The …

Nettet19. mar. 2014 · Rosetta is a UK-based firm that invests in portfolios of direct venture capital investments in the life science sector. Rosetta’s funds encompass life science companies across North America, Europe and Asia. For more information, contact Jonathan Hepple: +44 7775 654140 [email protected]

Nettet15. mar. 2024 · Dr. Jonathan Hepple is a Co-Founder and serves as a Partner at Rosetta Capital. He serves as a Board Member & OSI Advisor at Nucleome Therapeutics. He … 18 背番号http://lifesciences.instinctif.com/news/2024/03/mission-therapeutics-welcomes-co-founder-of-rosetta-capital-jonathan-hepple-to-its-board-of-directors 18 英数字NettetJonathan Hepple. chairman management Clanotech Sweden. Biography. Venture investor in life science companies since 1998. Founder of Rosetta Capital, a leading … 18 給付金Nettet24. mar. 2024 · Appointment follows Rosetta Capital acquisition of shareholding in Mission from Schroder Adveq ... 18 英尺NettetRosetta is headquartered in the UK and our team is located across Europe and Asia, providing us with broad geographic networks that have proven useful to support our … 18 色Nettet15. nov. 2024 · Rosetta Capital is committed to supporting the portfolio companies acquired in the transaction through the growth phase and has made several follow-on … 18 英寸等于多少厘米NettetJon Hepple is a co-founder of Rosetta. He has more than 20 years’ investment experience in the life sciences industry. He started his investment career at Rothschild … 18 翻訳